Medication Tapering
Psychiatric medication tapering guided by clinical judgment, continuity, and individualized risk assessment.
Medication tapering at Verigrate refers to the gradual, physician-supervised reduction of psychiatric medications when continued use no longer aligns with clinical response, risk profile, or long-term health. Decisions are informed by the individual’s treatment history, symptom patterns, and tolerance rather than standardized timelines.
Patients often wish to understand the symptoms that may occur during dose reduction. Additional clinical discussion can be found in our overviews of antidepressant withdrawal symptoms and benzodiazepine withdrawal symptoms.
Medications Commonly Considered
Antidepressants
Gabapentinoids
Long-term anxiety medications
Sleep medications
Benzodiazepines
Evaluation, tapering, and follow-up are conducted by a single physician. This continuity allows for nuanced adjustments, longitudinal assessment, and consistent clinical judgment throughout the tapering process.
Withdrawal Considerations
Withdrawal phenomena vary by medication class, dose, duration of use, and individual sensitivity, particularly in long-term benzodiazepine use. Common features may include anxiety, sleep disruption, sensory disturbances, and autonomic changes. Careful pacing and monitoring are used to reduce destabilization. Detailed discussion of withdrawal phenomena can be found in our clinical overviews of antidepressant tapering and benzodiazepine tapering.